Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Risk & Insurance
Article
Enlyte’s Dave Torrence Explains Why Integration Is Key to Managing Workers’ Comp Costs
Workers' Comp
Article
Specialty Solutions Spotlight: Why Translation Matters in Workers’ Compensation
How do translation services improve claim processes and outcomes?Language diversity is a significant consideration in the effective manage
Workers' Comp
News Release
California Utilization Review Regulation Updates Effective April 1, 2026
The California Office of Administrative Law has adopted the California Division of Workers’ Compensation ( CA DWC) rules, 8 CCR §§ 9767.6, 9781, 97
Risk & Insurance
Article
The Direct PT Paradox: Better Outcomes, Lower Adoption
Workers' Comp
Article
Match the Right Field Case Manager to the Claim
When a claim is moving fast, finding the right field case manager should not slow you down.
Workers' Comp
Article
Ask The Pharmacist: Understanding Morphine Equivalent Dose (MED) for Adjusters
What is Morphine Equivalent Dose and why does it matter in claims management?